A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis-Reference-Cited by-同舟云学术

A Review of Patisiran (ONPATTRO®) for the Treatment of Polyneuropathy in People with Hereditary Transthyretin Amyloidosis

Published:2020-08-12 Issue:2 Volume:9 Page:301-315
ISSN:2193-8253
Container-title:Neurology and Therapy
language:en
Short-container-title:Neurol Ther

Author:

Urits Ivan,Swanson Daniel,Swett Michael C.,Patel Anjana,Berardino Kevin,Amgalan Ariunzaya,Berger Amnon A.,Kassem Hisham^ORCID,Kaye Alan D.,Viswanath Omar

Publisher

Springer Science and Business Media LLC

Subject

Neurology (clinical),Neurology

Link

https://link.springer.com/content/pdf/10.1007/s40120-020-00208-1.pdf

Reference41 articles.

1. Vita G, Vita GL, Stancanelli C, Gentile L, Russo M, Mazzeo A. Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies. Neurol Sci. 2019;40(4):661–9.

2. Lamb YN, Deeks ED. Tafamidis: a review in transthyretin amyloidosis with polyneuropathy. Drugs. 2019;79(8):863–74.

3. Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve. 2007;36(4):411–23.

4. Frederick RL, Berk JL. Transthyretin (TTR) cardiac amyloidosis. Circulation. 2012;126(10):1286–300.

5. Adams D, Koike H, Slama M, Coelho T. Hereditary transthyretin amyloidosis: a model of medical progress for a fatal disease. Nat Rev Neurol. 2019;15(7):387–404.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of charged membranes for the ultrafiltration of siRNA;Journal of Membrane Science;2025-01

2. Suppressing upregulation of fibrinogen after polytrauma mitigates thrombosis in mice;Journal of Trauma and Acute Care Surgery;2024-09-06

3. Significance of VLPs in Vlp-circRNA vaccines: a vaccine candidate or delivery vehicle?;RNA Biology;2024-09-06

4. Protein is expressed in all major organs after intravenous infusion of mRNA-lipid nanoparticles in swine;Molecular Therapy - Methods & Clinical Development;2024-09

5. Gene editing in common cardiovascular diseases;Pharmacology & Therapeutics;2024-09